PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
2569356-0	1989	The effect of histamine-H1 receptor antagonism with terfenadine on concentration-related AMP-induced bronchoconstriction in asthma.	Adenosine Monophosphate	89-92	histamine receptor H1	Homo sapiens	14-35	
2569356-1	1989	Selective histamine-H1 receptor antagonists inhibit adenosine 5"-monophosphate (AMP)-induced bronchoconstriction by greater than 80% when expressed as a percentage inhibition of the FEV1 time-response curve following inhalation of the provocation concentration of AMP required to produce a 20% decrease in FEV1 from baseline (PC20).	adenosine 5"-monophosphate	52-78	histamine receptor H1	Homo sapiens	10-31	
2569356-1	1989	Selective histamine-H1 receptor antagonists inhibit adenosine 5"-monophosphate (AMP)-induced bronchoconstriction by greater than 80% when expressed as a percentage inhibition of the FEV1 time-response curve following inhalation of the provocation concentration of AMP required to produce a 20% decrease in FEV1 from baseline (PC20).	Adenosine Monophosphate	80-83	histamine receptor H1	Homo sapiens	10-31	
2569356-1	1989	Selective histamine-H1 receptor antagonists inhibit adenosine 5"-monophosphate (AMP)-induced bronchoconstriction by greater than 80% when expressed as a percentage inhibition of the FEV1 time-response curve following inhalation of the provocation concentration of AMP required to produce a 20% decrease in FEV1 from baseline (PC20).	Adenosine Monophosphate	264-267	histamine receptor H1	Homo sapiens	10-31	
2569356-4	1989	This 16.2-fold (range, 5.5-47.9) displacement to the right of the AMP concentration-response curve by a selective histamine-H1 receptor antagonist emphasizes the central role of histamine in the airways response to this nucleotide.	Adenosine Monophosphate	66-69	histamine receptor H1	Homo sapiens	114-135